Atlas Trials

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Clinical trial NCT02227368 · TERMINATED

Trial details

NCT number
NCT02227368
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral Artery Disease (PAD)
Start date
2014-10-20
Primary completion
2016-05-23
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.